unknown
Stage
2018
Founded
1
Investors
About
GentiBio is a clinical-stage biotechnology company that engineers regulatory T cells (EngTregs) to develop therapies for autoimmune and acute inflammatory diseases, including programs targeting Type 1 diabetes.
Explore GentiBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.